113 related articles for article (PubMed ID: 2453008)
1. Intrapleural natural beta interferon in the treatment of malignant pleural effusions.
Rosso R; Rimoldi R; Salvati F; De Palma M; Cinquegrana A; Nicolò G; Ardizzoni A; Fusco U; Capaccio A; Centofanti R
Oncology; 1988; 45(3):253-6. PubMed ID: 2453008
[TBL] [Abstract][Full Text] [Related]
2. Malignant pleural effusions.
Sahn SA
Clin Chest Med; 1985 Mar; 6(1):113-25. PubMed ID: 2988851
[TBL] [Abstract][Full Text] [Related]
3. [Natural beta-interferon for local use in the treatment of metastatic pleural effusion caused by neoplasm of the breast].
Terzoli E; Izzo F; Lucatelli S; Ranuzzi M
G Ital Oncol; 1989; 9(2-3):53-7. PubMed ID: 2767729
[TBL] [Abstract][Full Text] [Related]
4. Treatment of malignant pleural effusions with intracavitary Corynebacterium parvum.
Casali A; Gionfra T; Rinaldi M; Tonachella R; Tropea F; Venturo I; De Martino C; Curcio CG
Cancer; 1988 Aug; 62(4):806-11. PubMed ID: 3293763
[TBL] [Abstract][Full Text] [Related]
5. Malignant pleural effusions.
Dhillon DP; Spiro SG
Br J Hosp Med; 1983 Jun; 29(6):506-8, 510. PubMed ID: 6307448
[No Abstract] [Full Text] [Related]
6. Intrapleural administration of OK432 in cancer patients: activation of NK cells and reduction of suppressor cells.
Uchida A; Micksche M
Int J Cancer; 1983 Jan; 31(1):1-5. PubMed ID: 6219961
[TBL] [Abstract][Full Text] [Related]
7. Experience with intrapleural natural beta interferon in the treatment of malignant pleural effusions.
Cascinu S; Isidori PP; Fedeli A; Fedeli SL; Raspugli M; Rossi A; Ugolini M; Catalano G
Tumori; 1991 Jun; 77(3):237-8. PubMed ID: 1862552
[TBL] [Abstract][Full Text] [Related]
8. Drainage of recurrent pleural effusion via an implanted port and intrapleural catheter.
Leff RS; Eisenberg B; Baisden CE; Mosley KR; Messerschmidt GL
Ann Intern Med; 1986 Feb; 104(2):208-9. PubMed ID: 3946948
[No Abstract] [Full Text] [Related]
9. The treatment of malignant pleural effusions.
Anderson CB; Philpott GW; Ferguson TB
Cancer; 1974 Apr; 33(4):916-22. PubMed ID: 4362107
[No Abstract] [Full Text] [Related]
10. Interferon-alpha in serum and carcinomatous pleural effusion after repeated intrapleural injections of antitumor agents.
Kaneto E; Sasaki H; Tamura I; Kurimura O; Kurimura T
Biken J; 1983 Jun; 26(2):99-102. PubMed ID: 6318725
[TBL] [Abstract][Full Text] [Related]
11. [Intrapleural bleomycin for management of malignant pleural effusions].
Sugita T; Matsunaga K; Kobayashi H; Horikawa S; Suzuki Y; Nishiyama H; Maekawa N; Furuta H; Inui H; Fujimoto H
Gan To Kagaku Ryoho; 1995 Aug; 22(9):1203-7. PubMed ID: 7544964
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic treatment of recurrent malignant pleural effusions with intrapleurally administered Corynebacterium parvum. Clinical response is not associated with evidence of enhancement of local cellular-mediated immunity.
Rossi GA; Felletti R; Balbi B; Sacco O; Cosulich E; Risso A; Melioli G; Ravazzoni C
Am Rev Respir Dis; 1987 Apr; 135(4):885-90. PubMed ID: 2436513
[TBL] [Abstract][Full Text] [Related]
13. [Fibrin glue and tetracycline pleurodesis in recurrent malignant pleural effusions. A randomized comparative study].
Gust R; Kleine P; Fabel H
Med Klin (Munich); 1990 Jan; 85(1):18-23. PubMed ID: 1690342
[TBL] [Abstract][Full Text] [Related]
14. [Management of malignant pleural effusion by tetracycline pleurodesis].
Horváth T; Orosz E; Czenkár B
Orv Hetil; 1989 May; 130(20):1051-2. PubMed ID: 2471952
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
16. [Local administration of recombinant interferon-beta to patients with cancer-associated body cavity fluids].
Tanaka N; Terasawa A; Matsui T; Yamada J; Hizuta A; Ichikawa J; Nakayama F; Matsuda T; Orita K
Gan To Kagaku Ryoho; 1988 Feb; 15(2):237-41. PubMed ID: 3341785
[TBL] [Abstract][Full Text] [Related]
17. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
[TBL] [Abstract][Full Text] [Related]
18. [Anatomical study of the fibrosing action of Corynebacterium parvum in malignant pleural effusion].
Foresti V; Scolari N; Villa A; Parisio E
Minerva Med; 1989 Oct; 80(10):1069-72. PubMed ID: 2812462
[TBL] [Abstract][Full Text] [Related]
19. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
20. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
